Tismor Health and Wellness Pty Limited MARCS-CMS 588104 — December 05, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …
Read More »Pharma USFDA Warning Letter for Sunstar Guangzhou Ltd
Sunstar Guangzhou Ltd. MARCS-CMS 592906 — January 22, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »Pharma USFDA Warning Letter for Dental-Kosmetik GmbH & Co. KG
Dental-Kosmetik GmbH & Co. KG MARCS-CMS 591351 — January 16, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »Pharma USFDA Warning Letter for Baja Fur S.A. de C.V.
Baja Fur S.A. de C.V. MARCS-CMS 590791 — December 13, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »Pharma USFDA Warning Letter for Essnd Global
Essnd Global MARCS-CMS 595850 — February 14, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »Pharma USFDA Warning Letter for JHS Svendgaard Hygiene Products Ltd
JHS Svendgaard Hygiene Products Ltd MARCS-CMS 593473 — February 13, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »Pharma USFDA Warning Letter for KVK-Tech, Inc
KVK-Tech, Inc MARCS-CMS 592387 — February 11, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »Pharma USFDA Warning Letter for Chemland Co., Ltd.
Chemland Co., Ltd. MARCS-CMS 593158 — February 11, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »Pharma USFDA Warning Letter for Acino Products, LLC
Acino Products, LLC MARCS-CMS 589471 — February 10, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »Pharma USFDA Warning Letter for Guangzhou Tinci Materials Technology
Guangzhou Tinci Materials Technology Co., Ltd. MARCS-CMS 592199 — January 23, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …
Read More »Pharma USFDA Warning Letter for Windlas Healthcare Private Limited
Windlas Healthcare Private Limited MARCS-CMS 595494 — March 10, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »Pharma USFDA Warning Letter for Cipla Limited
Cipla Limited MARCS-CMS 597511 — February 25, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »Pharma USFDA Warning Letter for Hangzhou Linkeweier
Hangzhou Linkeweier Daily Chemicals Co., Ltd. MARCS-CMS 595492 — March 13, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …
Read More »Pharma USFDA Warning Letter for Derma Pharm
Derma Pharm A/S MARCS-CMS 596662 March 10, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »Pharma USFDA Warning Letter for Pfizer Healthcare India Private Limited
Pfizer Healthcare India Private Limited MARCS-CMS 594972 — March 25, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »Pharma USFDA Warning Letter for Trilogy Laboratories, LLC
Trilogy Laboratories, LLC MARCS-CMS 595087 — March 05, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »Pharma USFDA Warning Letter for FICOSOTA LTD
For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter Visit :https://pharmaguidances.com/shop/guideline/usfda-warning-letter/
Read More »Pharma USFDA Warning Letter Global Treat Srl
Global Treat Srl MARCS-CMS 596638 — March 31, 2020 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »Strip Packing Machine
Automatic Strip Packing Machine The Strip Packing Machine is designed to pack tablets and capsules within two heat-sealable foil. The machine has been designed to use cellophane Film, Cellophane Lumithene, Aluminum Foil, Polythene Film Laminates, and all heat-sealing papers for sealing. The Tablets / Capsules are charged into the hopper. …
Read More »SOP for Performance Qualification for Automatic Strip Packing Machine
Strip Packing Machine The Strip Packing Machine is designed for packing tablets and capsules within two heat-sealable foil. The machine has been designed to use cellophane Film, Cellophane Lumithene, Aluminum Foil, Polythene Film Laminates, and all heat-sealing papers for sealing purposes. The Tablets / Capsules are charged into the hopper. …
Read More »